Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The optimal tools for monitoring Crohn’s disease (CD) are controversial. We compared radiology plus ileocolonoscopy and radiology alone in terms of prognosis prediction and evaluated the agreement between radiologic and ileocolonoscopic findings in patients with CD. Methods: Patients with CD who were followed up with computed tomography enterography (CTE) or magnetic resonance enterography (MRE) alone or CTE or MRE plus ileocolonoscopy were retrospectively recruited. Time to relapse was investigated to evaluate the difference in prognosis using the log-rank and Cox regression tests, and the agreement between radiologic and ileocolonoscopic findings was determined using a kappa value. Results: A total of 501 patients with CD in clinical remission who underwent CTE or MRE and/or ileocolonoscopy were analyzed. Of these, 372 (74.3%) patients underwent CTE or MRE alone and 129 (25.7%) patients underwent CTE or MRE plus ileocolonoscopy. The cumulative maintenance rate of clinical remission between the two groups was not significantly different (p = 0.526, log-rank test). In multivariate analysis, age <40 years (hazard ratio [HR], 2.756; 95% confidence interval [CI], 1.263 to 6.013) and a history of steroid use (HR, 2.212; 95% CI, 1.258 to 3.577) were found to independently predict an increased risk for clinical relapse in patients with CD in clinical remission. Radiologic and ileocolonoscopic findings had a moderate degree of agreement (κ = 0.401, –0.094 to 0.142). The comparison of agreement between radiologic and ileocolonoscopic findings was the highest in the anastomotic site (κ = 0.749, –0.168 to 0.377). Conclusions: Radiology plus ileocolonoscopy was not superior to radiology alone in predicting the prognosis of CD.
Abstract
Background/Aims: The optimal tools for monitoring Crohn’s disease (CD) are controversial. We compared radiology plus ileocolonoscopy and radiology alone in terms of prognosis prediction and evaluated the agreement between radiologic and ileocolonoscopic findings in patients with CD. Methods: Patients with CD who were followed up with computed tomography enterography (CTE) or magnetic resonance enterography (MRE) alone or CTE or MRE plus ileocolonoscopy were retrospectively recruited. Time to relapse was investigated to evaluate the difference in prognosis using the log-rank and Cox regression tests, and the agreement between radiologic and ileocolonoscopic findings was determined using a kappa value. Results: A total of 501 patients with CD in clinical remission who underwent CTE or MRE and/or ileocolonoscopy were analyzed. Of these, 372 (74.3%) patients underwent CTE or MRE alone and 129 (25.7%) patients underwent CTE or MRE plus ileocolonoscopy. The cumulative maintenance rate of clinical remission between the two groups was not significantly different (p = 0.526, log-rank test). In multivariate analysis, age <40 years (hazard ratio [HR], 2.756; 95% confidence interval [CI], 1.263 to 6.013) and a history of steroid use (HR, 2.212; 95% CI, 1.258 to 3.577) were found to independently predict an increased risk for clinical relapse in patients with CD in clinical remission. Radiologic and ileocolonoscopic findings had a moderate degree of agreement (κ = 0.401, –0.094 to 0.142). The comparison of agreement between radiologic and ileocolonoscopic findings was the highest in the anastomotic site (κ = 0.749, –0.168 to 0.377). Conclusions: Radiology plus ileocolonoscopy was not superior to radiology alone in predicting the prognosis of CD.
참고문헌 (37)
- Baumgart DC, "Crohn’s disease", Lancet, 380, pp.1590~1605 (2012)
- Baert F, "Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease", Gastroenterology, 138, pp.463~468 (2010)
- Colombel JF, "Adalimumab induces deep remission in patients with Crohn’s disease", Clin Gastroenterol Hepatol, 12, pp.414~422 (2014)
- Landi B, "Endoscopic monitoring of Crohn’s disease treatment : a prospective, randomized clinical trial. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives", Gastroenterology, 102, pp.1647~1653 (1992)
- Ida Hilmi, "Capsule endoscopy in inflammatory bowel disease: when and how", Intestinal research, 18(3), pp.265~274 (2020), 대한장연구학회[DOI]
- Leighton JA, "ASGE guideline : endoscopy in the diagnosis and treatment of inflammatory bowel disease", Gastrointest Endosc, 63, pp.558~565 (2006)
- Makkar R, "Colonoscopic perforation in inflammatory bowel disease", Gastroenterol Hepatol(N Y), 9, pp.573~583 (2013)
- Gale HI, "Comparison of CT enterography and MR enterography imaging features of active Crohn disease in children and adolescents", Pediatr Radiol, 47, pp.1321~1328 (2017)
- Taylor SA, "Editorial : can MRI enterography be an efficient tool for patient selection in clinical trials?", Aliment Pharmacol Ther, 43, pp.643~644 (2016)
- Antonio Carlos da Silva Moraes, "Abdominal ultrasonography with color Doppler analysis in the assessment of ileal Crohn’s disease: comparison with magnetic resonance enterography", Intestinal research, 17(2), pp.227~236 (2019), 대한장연구학회[DOI]
- Makanyanga JC, "Current and future role of MR enterography in the management of Crohn disease", AJR Am J Roentgenol, 201, pp.56~64 (2013)
- Hordonneau C, "Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease : validation of quantitative index of activity", Am J Gastroenterol, 109, pp.89~98 (2014)
- Panes J, "Imaging techniques for assessment of inflammatory bowel disease : joint ECCO and ESGAR evidence-based consensus guidelines", J Crohns Colitis, 7, pp.556~585 (2013)
- Gomollon F, "3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016 : part 1. Diagnosis and medical management", J Crohns Colitis, 11, pp.3~25 (2017)
- Danese S, "Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease", Gastroenterology, 157, pp.1007~1018 (2019)
- Guglielmo FF, "Small bowel Crohn disease at CT and MR enterography : imaging atlas and glossary of terms", Radiographics, 40, pp.354~375 (2020)
- Tolan DJ, "MR enterographic manifestations of small bowel Crohn disease", Radiographics, 30, pp.367~384 (2010)
- Elsayes KM, "CT enterography : principles, trends, and interpretation of findings", Radiographics, 30, pp.1955~1970 (2010)
- Bruining DH, "Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease", Radiology, 286, pp.776~799 (2018)
- Freeman HJ, "Use of the Crohn’s disease activity index in clinical trials of biological agents", World J Gastroenterol, 14, pp.4127~4130 (2008)
- Kafil TS, "Cannabis for the treatment of Crohn’s disease", Cochrane Database Syst Rev, 11, pp.CD012853~ (2018)
- Stian Lydersen, "Cohens kappa – et mål på samsvar mellom observatører", Tidsskrift for Den norske legeforening (2018), Norwegian Medical Association[DOI]
- Serban ED, "Treat-to-target in Crohn’s disease : will transmural healing become a therapeutic endpoint?", World J Clin Cases, 6, pp.501~513 (2018)
- Peyrin-Biroulet L, "Selecting therapeutic targets in inflammatory bowel disease(STRIDE) : determining therapeutic goals for treat-to-target", Am J Gastroenterol, 110, pp.1324~1338 (2015)
- Bouguen G, "Treat to target : a proposed new paradigm for the management of Crohn’s disease", Clin Gastroenterol Hepatol, 13, pp.1042~1050 (2015)
- Van Assche G, "The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease : definitions and diagnosis", J Crohns Colitis, 4, pp.7~27 (2010)
- Buisson A, "Comparative acceptability and perceived clinical utility of monitoring tools : a nationwide survey of patients with inflammatory bowel disease", Inflamm Bowel Dis, 23, pp.1425~1433 (2017)
- Siddiki HA, "Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease", AJR Am J Roentgenol, 193, pp.113~121 (2009)
- Nehra AK, "Imaging findings of ileal inflammation at computed tomography and magnetic resonance enterography : what do they mean when ileoscopy and biopsy are negative?", J Crohns Colitis, 14, pp.455~464 (2020)
- Lopes S, "Monitoring Crohn’s disease activity : endoscopy, fecal markers and computed tomography enterography", Therap Adv Gastroenterol, 11, pp.1756284818769075~ (2018)
- Park Y, "Development of a novel predictive model for the clinical course of Crohn’s disease : results from the CONNECT study", Inflamm Bowel Dis, 23, pp.1071~1079 (2017)
- Solberg IC, "Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn’s disease(the IBSEN Study)", Inflamm Bowel Dis, 20, pp.60~68 (2014)
- Hara AK, "Using CT enterography to monitor Crohn’s disease activity : a preliminary study", AJR Am J Roentgenol, 190, pp.1512~1516 (2008)
- Rimola J, "Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease", Gut, 58, pp.1113~1120 (2009)
- Rozendorn N, "A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation", Therap Adv Gastroenterol, 11, pp.1756284818765956~ (2018)
- Rimola J, "Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease", J Gastroenterol, 52, pp.585~593 (2017)
- Buisson A, "Magnetic resonance index of activity(MaRIA)and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn’s disease", Dig Liver Dis, 49, pp.1211~1217 (2017)